SCY-770
Asset
Direct activator of AMP-activated protein kinase (AMPK)
- Stage
- Phase 1
- Modality
- Small molecule
- Target
- AMPK signalling
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Autosomal dominant polycystic kidney disease
Phase 1, globenewswire.com, 6 Oct 2026
In the full profile
- Targets and what it contains3
- Owner and partners1
- Evidence for its targets3
- Competitors7
- Aging relevance1
Every asset’s record: target, stage, trials and the evidence behind it.